Comparison of previously identified VTE risk alleles between the discovery cohort and populations of EA
. | Discovery cohort . | Previous studies . | |||||||
---|---|---|---|---|---|---|---|---|---|
Chr . | SNP . | Allele . | AF . | OR (95% CI) . | P* . | AF . | OR . | P . | Reference . |
1 | rs6025 (F5) | T | 0.0 | NA | NA | 0.06 | 2.56 | 1.40 × 10−12 | 11 |
11 | rs1799963 (F2) | A | 0.0 | NA | NA | 0.02 | 1.69 | 3.00 × 10−2 | 11 |
9 | rs687621 (ABO) | G | 0.43 | 1.55 (1.2-2.0) | 0.002 | 0.43 | 1.84 | 6.69 × 10−22 | 10 |
9 | rs505922 (ABO) | C | 0.36 | 1.52 (1.2-2.0) | 0.002 | 0.43 | 1.85 | 1.84 × 10−22 | 10 |
9 | rs657152 (ABO) | A | 0.44 | 1.39 (1.1-1.8) | 0.03 | 0.45 | 1.7 | 2.00 × 10−17 | 10 |
10 | rs78707713 (TSPAN15) | T | 0.97† | NA | NA | 0.88 | 1.28 | 5.74 × 10−11 | 29 |
19 | rs2288904 (SLC44A2) | G | 0.93 | 0.90 (0.5-1.5) | 0.75 | 0.79 | 1.19 | 1.07 × 10−9 | 29 |
. | Discovery cohort . | Previous studies . | |||||||
---|---|---|---|---|---|---|---|---|---|
Chr . | SNP . | Allele . | AF . | OR (95% CI) . | P* . | AF . | OR . | P . | Reference . |
1 | rs6025 (F5) | T | 0.0 | NA | NA | 0.06 | 2.56 | 1.40 × 10−12 | 11 |
11 | rs1799963 (F2) | A | 0.0 | NA | NA | 0.02 | 1.69 | 3.00 × 10−2 | 11 |
9 | rs687621 (ABO) | G | 0.43 | 1.55 (1.2-2.0) | 0.002 | 0.43 | 1.84 | 6.69 × 10−22 | 10 |
9 | rs505922 (ABO) | C | 0.36 | 1.52 (1.2-2.0) | 0.002 | 0.43 | 1.85 | 1.84 × 10−22 | 10 |
9 | rs657152 (ABO) | A | 0.44 | 1.39 (1.1-1.8) | 0.03 | 0.45 | 1.7 | 2.00 × 10−17 | 10 |
10 | rs78707713 (TSPAN15) | T | 0.97† | NA | NA | 0.88 | 1.28 | 5.74 × 10−11 | 29 |
19 | rs2288904 (SLC44A2) | G | 0.93 | 0.90 (0.5-1.5) | 0.75 | 0.79 | 1.19 | 1.07 × 10−9 | 29 |